VA launches program to bring precision cancer care to more veterans

NCT ID NCT06825715

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a three-part program to increase the use of precision oncology—genetic testing that guides personalized treatment—for veterans with advanced lung or prostate cancer. The program includes a patient education video, feedback to doctors on their testing patterns, and changes to the electronic medical record to simplify ordering genetic tests. Researchers will measure whether more eligible veterans receive genetic testing and, if a targetable mutation is found, whether they go on to receive a matching targeted therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multilevel intervention (patient education video, provider feedback, and electronic medical record changes)
What this could lead to
If successful, this approach could help more veterans receive personalized cancer treatments based on their tumor's genetic profile, potentially improving outcomes.
What could go wrong
This is an implementation study, not a test of a new drug. It may not show a direct benefit on survival or quality of life, and results may vary across different VA medical centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCERS OF THE PROSTATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA NY Harbor Healthcare System, New York, NY

    RECRUITING

    New York, New York, 10010-5011, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.